nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CA4—Alzheimer's disease	0.404	0.801	CbGaD
Methazolamide—CYP2D6—Alzheimer's disease	0.1	0.199	CbGaD
Methazolamide—CYP2D6—Rivastigmine—Alzheimer's disease	0.054	0.179	CbGbCtD
Methazolamide—CYP2C19—Memantine—Alzheimer's disease	0.0492	0.164	CbGbCtD
Methazolamide—CYP2C9—Donepezil—Alzheimer's disease	0.0472	0.157	CbGbCtD
Methazolamide—CYP2D6—Donepezil—Alzheimer's disease	0.0432	0.143	CbGbCtD
Methazolamide—CYP3A4—Rivastigmine—Alzheimer's disease	0.0343	0.114	CbGbCtD
Methazolamide—CYP2D6—Galantamine—Alzheimer's disease	0.0278	0.0925	CbGbCtD
Methazolamide—CYP3A4—Donepezil—Alzheimer's disease	0.0274	0.0912	CbGbCtD
Methazolamide—CYP3A4—Galantamine—Alzheimer's disease	0.0177	0.0588	CbGbCtD
Methazolamide—Myopia—Memantine—Alzheimer's disease	0.00593	0.0664	CcSEcCtD
Methazolamide—Acetazolamide—CA4—Alzheimer's disease	0.00414	1	CrCbGaD
Methazolamide—Calculus of kidney—Galantamine—Alzheimer's disease	0.00281	0.0314	CcSEcCtD
Methazolamide—Appetite absent—Rivastigmine—Alzheimer's disease	0.00254	0.0285	CcSEcCtD
Methazolamide—Nephrolithiasis—Galantamine—Alzheimer's disease	0.00229	0.0256	CcSEcCtD
Methazolamide—Calculus of kidney—Memantine—Alzheimer's disease	0.00197	0.0221	CcSEcCtD
Methazolamide—Calculus of kidney—Rivastigmine—Alzheimer's disease	0.00193	0.0216	CcSEcCtD
Methazolamide—Melaena—Galantamine—Alzheimer's disease	0.0018	0.0201	CcSEcCtD
Methazolamide—Glycosuria—Donepezil—Alzheimer's disease	0.00176	0.0197	CcSEcCtD
Methazolamide—Nephrolithiasis—Memantine—Alzheimer's disease	0.00161	0.018	CcSEcCtD
Methazolamide—Nephrolithiasis—Rivastigmine—Alzheimer's disease	0.00157	0.0176	CcSEcCtD
Methazolamide—Melaena—Donepezil—Alzheimer's disease	0.00139	0.0156	CcSEcCtD
Methazolamide—Melaena—Memantine—Alzheimer's disease	0.00126	0.0142	CcSEcCtD
Methazolamide—Melaena—Rivastigmine—Alzheimer's disease	0.00124	0.0139	CcSEcCtD
Methazolamide—Urine output increased—Memantine—Alzheimer's disease	0.00117	0.0131	CcSEcCtD
Methazolamide—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.00115	0.0128	CcSEcCtD
Methazolamide—Urine output increased—Rivastigmine—Alzheimer's disease	0.00114	0.0128	CcSEcCtD
Methazolamide—Polyuria—Memantine—Alzheimer's disease	0.00107	0.012	CcSEcCtD
Methazolamide—CA14—telencephalon—Alzheimer's disease	0.00106	0.0584	CbGeAlD
Methazolamide—Polyuria—Rivastigmine—Alzheimer's disease	0.00105	0.0117	CcSEcCtD
Methazolamide—Hepatic failure—Memantine—Alzheimer's disease	0.00105	0.0117	CcSEcCtD
Methazolamide—Haematuria—Galantamine—Alzheimer's disease	0.000981	0.011	CcSEcCtD
Methazolamide—CA12—forebrain—Alzheimer's disease	0.000896	0.0495	CbGeAlD
Methazolamide—Tinnitus—Galantamine—Alzheimer's disease	0.000861	0.00964	CcSEcCtD
Methazolamide—CA12—telencephalon—Alzheimer's disease	0.000824	0.0455	CbGeAlD
Methazolamide—Dysgeusia—Galantamine—Alzheimer's disease	0.000787	0.00882	CcSEcCtD
Methazolamide—Pancytopenia—Memantine—Alzheimer's disease	0.000771	0.00864	CcSEcCtD
Methazolamide—Haematuria—Donepezil—Alzheimer's disease	0.00076	0.00851	CcSEcCtD
Methazolamide—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000746	0.00835	CcSEcCtD
Methazolamide—Malaise—Galantamine—Alzheimer's disease	0.000725	0.00812	CcSEcCtD
Methazolamide—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000725	0.00812	CcSEcCtD
Methazolamide—Vertigo—Galantamine—Alzheimer's disease	0.000722	0.00809	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000718	0.00804	CcSEcCtD
Methazolamide—CA1—forebrain—Alzheimer's disease	0.00071	0.0392	CbGeAlD
Methazolamide—Drowsiness—Rivastigmine—Alzheimer's disease	0.000708	0.00793	CcSEcCtD
Methazolamide—CA7—cerebellum—Alzheimer's disease	0.000705	0.0389	CbGeAlD
Methazolamide—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000702	0.00786	CcSEcCtD
Methazolamide—Convulsion—Galantamine—Alzheimer's disease	0.000697	0.0078	CcSEcCtD
Methazolamide—Haematuria—Memantine—Alzheimer's disease	0.00069	0.00773	CcSEcCtD
Methazolamide—Discomfort—Galantamine—Alzheimer's disease	0.000676	0.00757	CcSEcCtD
Methazolamide—Agranulocytosis—Memantine—Alzheimer's disease	0.000676	0.00757	CcSEcCtD
Methazolamide—Haematuria—Rivastigmine—Alzheimer's disease	0.000675	0.00756	CcSEcCtD
Methazolamide—Tinnitus—Donepezil—Alzheimer's disease	0.000667	0.00747	CcSEcCtD
Methazolamide—Confusional state—Galantamine—Alzheimer's disease	0.000662	0.00741	CcSEcCtD
Methazolamide—CA1—telencephalon—Alzheimer's disease	0.000653	0.0361	CbGeAlD
Methazolamide—Anorexia—Galantamine—Alzheimer's disease	0.000625	0.00701	CcSEcCtD
Methazolamide—CA9—cerebellum—Alzheimer's disease	0.000619	0.0342	CbGeAlD
Methazolamide—Erythema multiforme—Memantine—Alzheimer's disease	0.000614	0.00688	CcSEcCtD
Methazolamide—Dysgeusia—Donepezil—Alzheimer's disease	0.00061	0.00683	CcSEcCtD
Methazolamide—Tinnitus—Memantine—Alzheimer's disease	0.000606	0.00679	CcSEcCtD
Methazolamide—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000601	0.00673	CcSEcCtD
Methazolamide—Tinnitus—Rivastigmine—Alzheimer's disease	0.000593	0.00664	CcSEcCtD
Methazolamide—Paraesthesia—Galantamine—Alzheimer's disease	0.000589	0.0066	CcSEcCtD
Methazolamide—CA14—cerebellum—Alzheimer's disease	0.000587	0.0324	CbGeAlD
Methazolamide—Somnolence—Galantamine—Alzheimer's disease	0.000583	0.00653	CcSEcCtD
Methazolamide—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000578	0.00647	CcSEcCtD
Methazolamide—Dyspepsia—Galantamine—Alzheimer's disease	0.000578	0.00647	CcSEcCtD
Methazolamide—CA7—brain—Alzheimer's disease	0.000573	0.0316	CbGeAlD
Methazolamide—Decreased appetite—Galantamine—Alzheimer's disease	0.00057	0.00639	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000566	0.00634	CcSEcCtD
Methazolamide—Fatigue—Galantamine—Alzheimer's disease	0.000566	0.00634	CcSEcCtD
Methazolamide—Malaise—Donepezil—Alzheimer's disease	0.000562	0.00629	CcSEcCtD
Methazolamide—Vertigo—Donepezil—Alzheimer's disease	0.00056	0.00627	CcSEcCtD
Methazolamide—CA4—forebrain—Alzheimer's disease	0.000555	0.0306	CbGeAlD
Methazolamide—Dysgeusia—Memantine—Alzheimer's disease	0.000554	0.0062	CcSEcCtD
Methazolamide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000542	0.00607	CcSEcCtD
Methazolamide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000541	0.00606	CcSEcCtD
Methazolamide—Convulsion—Donepezil—Alzheimer's disease	0.00054	0.00605	CcSEcCtD
Methazolamide—Ill-defined disorder—Memantine—Alzheimer's disease	0.000525	0.00588	CcSEcCtD
Methazolamide—Discomfort—Donepezil—Alzheimer's disease	0.000524	0.00587	CcSEcCtD
Methazolamide—CA2—embryo—Alzheimer's disease	0.00052	0.0287	CbGeAlD
Methazolamide—Body temperature increased—Galantamine—Alzheimer's disease	0.000519	0.00581	CcSEcCtD
Methazolamide—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000513	0.00575	CcSEcCtD
Methazolamide—Confusional state—Donepezil—Alzheimer's disease	0.000513	0.00574	CcSEcCtD
Methazolamide—CA4—telencephalon—Alzheimer's disease	0.00051	0.0282	CbGeAlD
Methazolamide—Malaise—Memantine—Alzheimer's disease	0.00051	0.00571	CcSEcCtD
Methazolamide—Vertigo—Memantine—Alzheimer's disease	0.000508	0.00569	CcSEcCtD
Methazolamide—Leukopenia—Memantine—Alzheimer's disease	0.000506	0.00567	CcSEcCtD
Methazolamide—Malaise—Rivastigmine—Alzheimer's disease	0.000499	0.00559	CcSEcCtD
Methazolamide—Vertigo—Rivastigmine—Alzheimer's disease	0.000497	0.00557	CcSEcCtD
Methazolamide—Convulsion—Memantine—Alzheimer's disease	0.00049	0.00549	CcSEcCtD
Methazolamide—CA12—nervous system—Alzheimer's disease	0.000487	0.0269	CbGeAlD
Methazolamide—Anorexia—Donepezil—Alzheimer's disease	0.000485	0.00543	CcSEcCtD
Methazolamide—Convulsion—Rivastigmine—Alzheimer's disease	0.000479	0.00537	CcSEcCtD
Methazolamide—CA14—brain—Alzheimer's disease	0.000477	0.0263	CbGeAlD
Methazolamide—Discomfort—Memantine—Alzheimer's disease	0.000476	0.00533	CcSEcCtD
Methazolamide—Asthenia—Galantamine—Alzheimer's disease	0.000471	0.00527	CcSEcCtD
Methazolamide—CA12—central nervous system—Alzheimer's disease	0.000468	0.0259	CbGeAlD
Methazolamide—Confusional state—Memantine—Alzheimer's disease	0.000466	0.00521	CcSEcCtD
Methazolamide—Discomfort—Rivastigmine—Alzheimer's disease	0.000465	0.00521	CcSEcCtD
Methazolamide—CA2—forebrain—Alzheimer's disease	0.00046	0.0254	CbGeAlD
Methazolamide—Paraesthesia—Donepezil—Alzheimer's disease	0.000457	0.00511	CcSEcCtD
Methazolamide—Confusional state—Rivastigmine—Alzheimer's disease	0.000455	0.0051	CcSEcCtD
Methazolamide—Somnolence—Donepezil—Alzheimer's disease	0.000452	0.00506	CcSEcCtD
Methazolamide—Diarrhoea—Galantamine—Alzheimer's disease	0.000449	0.00503	CcSEcCtD
Methazolamide—Dyspepsia—Donepezil—Alzheimer's disease	0.000448	0.00501	CcSEcCtD
Methazolamide—Decreased appetite—Donepezil—Alzheimer's disease	0.000442	0.00495	CcSEcCtD
Methazolamide—Anorexia—Memantine—Alzheimer's disease	0.00044	0.00493	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000439	0.00492	CcSEcCtD
Methazolamide—Fatigue—Donepezil—Alzheimer's disease	0.000438	0.00491	CcSEcCtD
Methazolamide—CA5B—nervous system—Alzheimer's disease	0.000437	0.0241	CbGeAlD
Methazolamide—Anorexia—Rivastigmine—Alzheimer's disease	0.000431	0.00482	CcSEcCtD
Methazolamide—CA2—telencephalon—Alzheimer's disease	0.000423	0.0234	CbGeAlD
Methazolamide—CA5B—central nervous system—Alzheimer's disease	0.00042	0.0232	CbGeAlD
Methazolamide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000419	0.00469	CcSEcCtD
Methazolamide—Vomiting—Galantamine—Alzheimer's disease	0.000417	0.00467	CcSEcCtD
Methazolamide—SLC22A6—brain—Alzheimer's disease	0.000415	0.0229	CbGeAlD
Methazolamide—Paraesthesia—Memantine—Alzheimer's disease	0.000415	0.00464	CcSEcCtD
Methazolamide—Rash—Galantamine—Alzheimer's disease	0.000414	0.00463	CcSEcCtD
Methazolamide—Dermatitis—Galantamine—Alzheimer's disease	0.000413	0.00463	CcSEcCtD
Methazolamide—Headache—Galantamine—Alzheimer's disease	0.000411	0.0046	CcSEcCtD
Methazolamide—Somnolence—Memantine—Alzheimer's disease	0.00041	0.0046	CcSEcCtD
Methazolamide—Dyspepsia—Memantine—Alzheimer's disease	0.000406	0.00455	CcSEcCtD
Methazolamide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000406	0.00454	CcSEcCtD
Methazolamide—Urticaria—Donepezil—Alzheimer's disease	0.000404	0.00452	CcSEcCtD
Methazolamide—Body temperature increased—Donepezil—Alzheimer's disease	0.000402	0.0045	CcSEcCtD
Methazolamide—Somnolence—Rivastigmine—Alzheimer's disease	0.000402	0.0045	CcSEcCtD
Methazolamide—Decreased appetite—Memantine—Alzheimer's disease	0.000401	0.0045	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000399	0.00446	CcSEcCtD
Methazolamide—Fatigue—Memantine—Alzheimer's disease	0.000398	0.00446	CcSEcCtD
Methazolamide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000398	0.00445	CcSEcCtD
Methazolamide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000393	0.0044	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00039	0.00437	CcSEcCtD
Methazolamide—Nausea—Galantamine—Alzheimer's disease	0.00039	0.00437	CcSEcCtD
Methazolamide—Fatigue—Rivastigmine—Alzheimer's disease	0.000389	0.00436	CcSEcCtD
Methazolamide—CA1—nervous system—Alzheimer's disease	0.000385	0.0213	CbGeAlD
Methazolamide—Feeling abnormal—Memantine—Alzheimer's disease	0.00038	0.00426	CcSEcCtD
Methazolamide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000372	0.00417	CcSEcCtD
Methazolamide—CA12—brain—Alzheimer's disease	0.000372	0.0205	CbGeAlD
Methazolamide—CA1—central nervous system—Alzheimer's disease	0.000371	0.0205	CbGeAlD
Methazolamide—Urticaria—Memantine—Alzheimer's disease	0.000367	0.00411	CcSEcCtD
Methazolamide—Body temperature increased—Memantine—Alzheimer's disease	0.000365	0.00409	CcSEcCtD
Methazolamide—Asthenia—Donepezil—Alzheimer's disease	0.000365	0.00409	CcSEcCtD
Methazolamide—Urticaria—Rivastigmine—Alzheimer's disease	0.000359	0.00402	CcSEcCtD
Methazolamide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000357	0.004	CcSEcCtD
Methazolamide—Diarrhoea—Donepezil—Alzheimer's disease	0.000348	0.0039	CcSEcCtD
Methazolamide—CYP2E1—telencephalon—Alzheimer's disease	0.000339	0.0187	CbGeAlD
Methazolamide—CA5B—brain—Alzheimer's disease	0.000334	0.0184	CbGeAlD
Methazolamide—Asthenia—Memantine—Alzheimer's disease	0.000331	0.00371	CcSEcCtD
Methazolamide—Asthenia—Rivastigmine—Alzheimer's disease	0.000324	0.00363	CcSEcCtD
Methazolamide—Vomiting—Donepezil—Alzheimer's disease	0.000323	0.00362	CcSEcCtD
Methazolamide—Rash—Donepezil—Alzheimer's disease	0.000321	0.00359	CcSEcCtD
Methazolamide—Dermatitis—Donepezil—Alzheimer's disease	0.00032	0.00359	CcSEcCtD
Methazolamide—Headache—Donepezil—Alzheimer's disease	0.000319	0.00357	CcSEcCtD
Methazolamide—Diarrhoea—Memantine—Alzheimer's disease	0.000316	0.00354	CcSEcCtD
Methazolamide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000309	0.00346	CcSEcCtD
Methazolamide—Nausea—Donepezil—Alzheimer's disease	0.000302	0.00338	CcSEcCtD
Methazolamide—CA4—nervous system—Alzheimer's disease	0.000301	0.0166	CbGeAlD
Methazolamide—CA1—brain—Alzheimer's disease	0.000295	0.0163	CbGeAlD
Methazolamide—Vomiting—Memantine—Alzheimer's disease	0.000294	0.00329	CcSEcCtD
Methazolamide—CYP2D6—forebrain—Alzheimer's disease	0.000292	0.0161	CbGeAlD
Methazolamide—Rash—Memantine—Alzheimer's disease	0.000291	0.00326	CcSEcCtD
Methazolamide—Dermatitis—Memantine—Alzheimer's disease	0.000291	0.00326	CcSEcCtD
Methazolamide—CA4—central nervous system—Alzheimer's disease	0.00029	0.016	CbGeAlD
Methazolamide—Headache—Memantine—Alzheimer's disease	0.000289	0.00324	CcSEcCtD
Methazolamide—Vomiting—Rivastigmine—Alzheimer's disease	0.000287	0.00322	CcSEcCtD
Methazolamide—Rash—Rivastigmine—Alzheimer's disease	0.000285	0.00319	CcSEcCtD
Methazolamide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000285	0.00319	CcSEcCtD
Methazolamide—CA4—cerebellum—Alzheimer's disease	0.000284	0.0157	CbGeAlD
Methazolamide—Headache—Rivastigmine—Alzheimer's disease	0.000283	0.00317	CcSEcCtD
Methazolamide—Nausea—Memantine—Alzheimer's disease	0.000274	0.00307	CcSEcCtD
Methazolamide—CYP2D6—telencephalon—Alzheimer's disease	0.000269	0.0148	CbGeAlD
Methazolamide—Nausea—Rivastigmine—Alzheimer's disease	0.000268	0.003	CcSEcCtD
Methazolamide—CA2—nervous system—Alzheimer's disease	0.00025	0.0138	CbGeAlD
Methazolamide—CA2—central nervous system—Alzheimer's disease	0.000241	0.0133	CbGeAlD
Methazolamide—CA2—cerebellum—Alzheimer's disease	0.000235	0.013	CbGeAlD
Methazolamide—CA4—brain—Alzheimer's disease	0.00023	0.0127	CbGeAlD
Methazolamide—CYP2E1—nervous system—Alzheimer's disease	0.0002	0.0111	CbGeAlD
Methazolamide—CYP2E1—central nervous system—Alzheimer's disease	0.000193	0.0106	CbGeAlD
Methazolamide—CA2—brain—Alzheimer's disease	0.000191	0.0105	CbGeAlD
Methazolamide—CYP2E1—cerebellum—Alzheimer's disease	0.000188	0.0104	CbGeAlD
Methazolamide—CYP3A4—nervous system—Alzheimer's disease	0.000161	0.0089	CbGeAlD
Methazolamide—CYP2D6—nervous system—Alzheimer's disease	0.000159	0.00876	CbGeAlD
Methazolamide—CYP3A4—central nervous system—Alzheimer's disease	0.000155	0.00857	CbGeAlD
Methazolamide—CYP2E1—brain—Alzheimer's disease	0.000153	0.00846	CbGeAlD
Methazolamide—CYP2D6—central nervous system—Alzheimer's disease	0.000153	0.00843	CbGeAlD
Methazolamide—CYP2D6—cerebellum—Alzheimer's disease	0.000149	0.00824	CbGeAlD
Methazolamide—CYP2D6—brain—Alzheimer's disease	0.000121	0.00669	CbGeAlD
Methazolamide—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	1.83e-05	0.000221	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HSD17B10—Alzheimer's disease	1.81e-05	0.000217	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PPARGC1A—Alzheimer's disease	1.81e-05	0.000217	CbGpPWpGaD
Methazolamide—CA1—Metabolism—HMOX1—Alzheimer's disease	1.8e-05	0.000216	CbGpPWpGaD
Methazolamide—CA4—Metabolism—LPL—Alzheimer's disease	1.79e-05	0.000215	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PPARG—Alzheimer's disease	1.77e-05	0.000213	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PPARG—Alzheimer's disease	1.77e-05	0.000213	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP46A1—Alzheimer's disease	1.74e-05	0.000209	CbGpPWpGaD
Methazolamide—CA7—Metabolism—INS—Alzheimer's disease	1.73e-05	0.000209	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—INS—Alzheimer's disease	1.73e-05	0.000209	CbGpPWpGaD
Methazolamide—CA2—Metabolism—LPL—Alzheimer's disease	1.71e-05	0.000206	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CA4—Alzheimer's disease	1.71e-05	0.000206	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	1.71e-05	0.000206	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ND1—Alzheimer's disease	1.68e-05	0.000202	CbGpPWpGaD
Methazolamide—CA14—Metabolism—NOS3—Alzheimer's disease	1.67e-05	0.000201	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.67e-05	0.000201	CbGpPWpGaD
Methazolamide—CA1—Metabolism—LPL—Alzheimer's disease	1.64e-05	0.000198	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PPARG—Alzheimer's disease	1.64e-05	0.000197	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—NOS3—Alzheimer's disease	1.63e-05	0.000196	CbGpPWpGaD
Methazolamide—CA6—Metabolism—NOS3—Alzheimer's disease	1.63e-05	0.000196	CbGpPWpGaD
Methazolamide—CA4—Metabolism—MTHFR—Alzheimer's disease	1.61e-05	0.000194	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	1.61e-05	0.000193	CbGpPWpGaD
Methazolamide—CA12—Metabolism—INS—Alzheimer's disease	1.61e-05	0.000193	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PPARGC1A—Alzheimer's disease	1.59e-05	0.000191	CbGpPWpGaD
Methazolamide—CA9—Metabolism—HMOX1—Alzheimer's disease	1.58e-05	0.00019	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CA4—Alzheimer's disease	1.57e-05	0.000189	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CA4—Alzheimer's disease	1.56e-05	0.000187	CbGpPWpGaD
Methazolamide—CA2—Metabolism—MTHFR—Alzheimer's disease	1.54e-05	0.000186	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PTGS2—Alzheimer's disease	1.53e-05	0.000184	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	1.52e-05	0.000183	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.52e-05	0.000183	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—NOS3—Alzheimer's disease	1.52e-05	0.000183	CbGpPWpGaD
Methazolamide—CA7—Metabolism—NOS3—Alzheimer's disease	1.52e-05	0.000183	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CALM1—Alzheimer's disease	1.5e-05	0.000181	CbGpPWpGaD
Methazolamide—CA4—Metabolism—APOE—Alzheimer's disease	1.5e-05	0.00018	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PTGS2—Alzheimer's disease	1.49e-05	0.000179	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PTGS2—Alzheimer's disease	1.49e-05	0.000179	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CAV1—Alzheimer's disease	1.49e-05	0.000179	CbGpPWpGaD
Methazolamide—CA1—Metabolism—MTHFR—Alzheimer's disease	1.48e-05	0.000178	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.48e-05	0.000178	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	1.46e-05	0.000176	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PLD3—Alzheimer's disease	1.45e-05	0.000175	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.45e-05	0.000175	CbGpPWpGaD
Methazolamide—CA9—Metabolism—LPL—Alzheimer's disease	1.44e-05	0.000174	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CALM1—Alzheimer's disease	1.44e-05	0.000174	CbGpPWpGaD
Methazolamide—CA2—Metabolism—APOE—Alzheimer's disease	1.44e-05	0.000173	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.44e-05	0.000173	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CAV1—Alzheimer's disease	1.42e-05	0.000171	CbGpPWpGaD
Methazolamide—CA12—Metabolism—NOS3—Alzheimer's disease	1.41e-05	0.000169	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.4e-05	0.000169	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	1.39e-05	0.000168	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PTGS2—Alzheimer's disease	1.39e-05	0.000167	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PTGS2—Alzheimer's disease	1.39e-05	0.000167	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	1.39e-05	0.000167	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CALM1—Alzheimer's disease	1.38e-05	0.000166	CbGpPWpGaD
Methazolamide—CA1—Metabolism—APOE—Alzheimer's disease	1.38e-05	0.000166	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CAV1—Alzheimer's disease	1.37e-05	0.000164	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.36e-05	0.000164	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	1.34e-05	0.000161	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.34e-05	0.000161	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PLD3—Alzheimer's disease	1.32e-05	0.000159	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.32e-05	0.000159	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.31e-05	0.000158	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PPARG—Alzheimer's disease	1.31e-05	0.000157	CbGpPWpGaD
Methazolamide—CA9—Metabolism—MTHFR—Alzheimer's disease	1.3e-05	0.000157	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ND1—Alzheimer's disease	1.29e-05	0.000156	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PTGS2—Alzheimer's disease	1.29e-05	0.000155	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.28e-05	0.000154	CbGpPWpGaD
Methazolamide—CA4—Metabolism—INS—Alzheimer's disease	1.28e-05	0.000154	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	1.27e-05	0.000153	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.27e-05	0.000152	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PPARG—Alzheimer's disease	1.25e-05	0.000151	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.24e-05	0.000149	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.23e-05	0.000148	CbGpPWpGaD
Methazolamide—CA2—Metabolism—INS—Alzheimer's disease	1.23e-05	0.000148	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.22e-05	0.000147	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CALM1—Alzheimer's disease	1.22e-05	0.000146	CbGpPWpGaD
Methazolamide—CA9—Metabolism—APOE—Alzheimer's disease	1.21e-05	0.000146	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.21e-05	0.000145	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PPARG—Alzheimer's disease	1.2e-05	0.000144	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CAV1—Alzheimer's disease	1.2e-05	0.000144	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.19e-05	0.000143	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.18e-05	0.000142	CbGpPWpGaD
Methazolamide—CA1—Metabolism—INS—Alzheimer's disease	1.18e-05	0.000142	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.16e-05	0.000139	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.15e-05	0.000139	CbGpPWpGaD
Methazolamide—CA4—Metabolism—NOS3—Alzheimer's disease	1.12e-05	0.000135	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TPI1—Alzheimer's disease	1.08e-05	0.00013	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CHAT—Alzheimer's disease	1.08e-05	0.00013	CbGpPWpGaD
Methazolamide—CA2—Metabolism—NOS3—Alzheimer's disease	1.08e-05	0.00013	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.06e-05	0.000127	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PPARG—Alzheimer's disease	1.05e-05	0.000127	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MAOB—Alzheimer's disease	1.04e-05	0.000125	CbGpPWpGaD
Methazolamide—CA9—Metabolism—INS—Alzheimer's disease	1.03e-05	0.000125	CbGpPWpGaD
Methazolamide—CA1—Metabolism—NOS3—Alzheimer's disease	1.03e-05	0.000124	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.03e-05	0.000124	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PTGS2—Alzheimer's disease	1.03e-05	0.000124	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	9.98e-06	0.00012	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	9.98e-06	0.00012	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PTGS2—Alzheimer's disease	9.85e-06	0.000119	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	9.66e-06	0.000116	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—A2M—Alzheimer's disease	9.64e-06	0.000116	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PTGS2—Alzheimer's disease	9.44e-06	0.000114	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	9.16e-06	0.00011	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	9.1e-06	0.000109	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.08e-06	0.000109	CbGpPWpGaD
Methazolamide—CA9—Metabolism—NOS3—Alzheimer's disease	9.07e-06	0.000109	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLD3—Alzheimer's disease	8.74e-06	0.000105	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ACHE—Alzheimer's disease	8.39e-06	0.000101	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	8.38e-06	0.000101	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TPI1—Alzheimer's disease	8.34e-06	0.0001	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CHAT—Alzheimer's disease	8.34e-06	0.0001	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PTGS2—Alzheimer's disease	8.3e-06	9.99e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	8.29e-06	9.98e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	8.28e-06	9.97e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	8.06e-06	9.7e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MAOB—Alzheimer's disease	8e-06	9.63e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ENO1—Alzheimer's disease	7.86e-06	9.46e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	7.86e-06	9.46e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ND1—Alzheimer's disease	7.79e-06	9.37e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	7.71e-06	9.27e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	7.7e-06	9.27e-05	CbGpPWpGaD
Methazolamide—CA14—Metabolism—AKT1—Alzheimer's disease	7.68e-06	9.24e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CHAT—Alzheimer's disease	7.67e-06	9.24e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TPI1—Alzheimer's disease	7.67e-06	9.24e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	7.61e-06	9.16e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CHAT—Alzheimer's disease	7.61e-06	9.16e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TPI1—Alzheimer's disease	7.61e-06	9.16e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	7.54e-06	9.08e-05	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—AKT1—Alzheimer's disease	7.48e-06	9.01e-05	CbGpPWpGaD
Methazolamide—CA6—Metabolism—AKT1—Alzheimer's disease	7.48e-06	9.01e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—A2M—Alzheimer's disease	7.44e-06	8.95e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MAOB—Alzheimer's disease	7.36e-06	8.86e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—BCHE—Alzheimer's disease	7.31e-06	8.79e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MAOB—Alzheimer's disease	7.29e-06	8.78e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	7.08e-06	8.52e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	7.02e-06	8.45e-05	CbGpPWpGaD
Methazolamide—CA7—Metabolism—AKT1—Alzheimer's disease	6.99e-06	8.41e-05	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—AKT1—Alzheimer's disease	6.99e-06	8.41e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.94e-06	8.35e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	6.89e-06	8.3e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	6.88e-06	8.28e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—A2M—Alzheimer's disease	6.84e-06	8.23e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—A2M—Alzheimer's disease	6.78e-06	8.16e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	6.68e-06	8.04e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.63e-06	7.98e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—AKT1—Alzheimer's disease	6.47e-06	7.79e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ACHE—Alzheimer's disease	6.47e-06	7.79e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	6.4e-06	7.7e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ENO1—Alzheimer's disease	6.06e-06	7.3e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	6.06e-06	7.3e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.05e-06	7.28e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ACHE—Alzheimer's disease	5.95e-06	7.16e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	5.95e-06	7.16e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ACHE—Alzheimer's disease	5.9e-06	7.1e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	5.88e-06	7.08e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	5.83e-06	7.02e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	5.76e-06	6.93e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	5.73e-06	6.9e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—BCHE—Alzheimer's disease	5.64e-06	6.78e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ENO1—Alzheimer's disease	5.58e-06	6.71e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	5.58e-06	6.71e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	5.53e-06	6.65e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ENO1—Alzheimer's disease	5.53e-06	6.65e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	5.42e-06	6.52e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	5.32e-06	6.4e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—LPL—Alzheimer's disease	5.24e-06	6.31e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.22e-06	6.28e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—BCHE—Alzheimer's disease	5.18e-06	6.24e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—AKT1—Alzheimer's disease	5.16e-06	6.21e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	5.15e-06	6.2e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—BCHE—Alzheimer's disease	5.14e-06	6.19e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.02e-06	6.04e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.02e-06	6.04e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—AKT1—Alzheimer's disease	4.95e-06	5.96e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	4.89e-06	5.89e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	4.85e-06	5.84e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MAOB—Alzheimer's disease	4.81e-06	5.79e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.76e-06	5.72e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—AKT1—Alzheimer's disease	4.74e-06	5.71e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	4.74e-06	5.71e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	4.72e-06	5.68e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	4.7e-06	5.66e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	4.63e-06	5.57e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.47e-06	5.38e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	4.44e-06	5.35e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	4.42e-06	5.32e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CALM1—Alzheimer's disease	4.41e-06	5.31e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APOE—Alzheimer's disease	4.39e-06	5.29e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CAV1—Alzheimer's disease	4.35e-06	5.24e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—AKT1—Alzheimer's disease	4.17e-06	5.02e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.09e-06	4.92e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.07e-06	4.9e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	4.05e-06	4.88e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—LPL—Alzheimer's disease	4.05e-06	4.87e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	4.03e-06	4.85e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.89e-06	4.68e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.85e-06	4.63e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPARG—Alzheimer's disease	3.83e-06	4.61e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—INS—Alzheimer's disease	3.75e-06	4.52e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.72e-06	4.48e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—LPL—Alzheimer's disease	3.69e-06	4.44e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.65e-06	4.39e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.65e-06	4.39e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	3.64e-06	4.38e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.58e-06	4.3e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CALM1—Alzheimer's disease	3.4e-06	4.1e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOE—Alzheimer's disease	3.39e-06	4.08e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.39e-06	4.08e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CAV1—Alzheimer's disease	3.36e-06	4.04e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.35e-06	4.03e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	3.32e-06	4e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NOS3—Alzheimer's disease	3.29e-06	3.96e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.2e-06	3.85e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.13e-06	3.77e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.12e-06	3.75e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CALM1—Alzheimer's disease	3.1e-06	3.73e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.1e-06	3.73e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOE—Alzheimer's disease	3.09e-06	3.72e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.09e-06	3.72e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CAV1—Alzheimer's disease	3.06e-06	3.69e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	3.01e-06	3.62e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.95e-06	3.55e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—INS—Alzheimer's disease	2.9e-06	3.49e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.72e-06	3.27e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPARG—Alzheimer's disease	2.69e-06	3.24e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.67e-06	3.22e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—INS—Alzheimer's disease	2.66e-06	3.21e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.66e-06	3.2e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—INS—Alzheimer's disease	2.64e-06	3.18e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.54e-06	3.06e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.43e-06	2.93e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.34e-06	2.81e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	2.32e-06	2.8e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.32e-06	2.79e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.19e-06	2.64e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.14e-06	2.57e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.12e-06	2.55e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.05e-06	2.46e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.04e-06	2.45e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.02e-06	2.43e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.78e-06	2.14e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—INS—Alzheimer's disease	1.74e-06	2.1e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.53e-06	1.84e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKT1—Alzheimer's disease	1.51e-06	1.82e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.4e-06	1.68e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.17e-06	1.41e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.07e-06	1.29e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.06e-06	1.28e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	7.02e-07	8.45e-06	CbGpPWpGaD
